Viewing Study NCT06341595


Ignite Creation Date: 2025-12-24 @ 1:13 PM
Ignite Modification Date: 2026-01-04 @ 8:59 AM
Study NCT ID: NCT06341595
Status: RECRUITING
Last Update Posted: 2024-04-02
First Post: 2023-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module